$BRNX Cashflow Statement | Understand Stock

$BRNX

$0.76 -$0.01 (1.63%) Close

$BRNX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Net cash used for operating activities (see Appendix A)
Recognition of lease liability and right-of-use asset
Derecognition of lease liability
Derecognition of right of use asset
Borrowing costs capitalized
C. INTEREST PAYMENTS (included in financing activities items)
D. INTEREST INCOME (included in investing activities items)
Purchase of equipment
Installation of a production facility, less participation by the Israeli Innovation Authority (Note 8)
Investment in joint venture
Restricted deposits and interest thereon, net
Net cash used for investing activities
Proceeds from issuance of shares and warrants, net
Loan received from EIB
Repayment of bank loan and interest thereon
Payments with respect to lease liabilities and interest thereon
Repayments of royalty liability
CASH FLOWS - OPERATING ACTIVITIES:
Net Loss, as above
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation (Note 7)
Impairment and closure net loss on Rotem 1 project
Non-cash interest and exchange rate differences, net
Fair value adjustment of warrants’ liability
Share in equity loss of joint venture
Warrants issuance costs
Loss from write-down of production line
Gain on sale of equipment
Share-based compensation (Note 11D)
Other

Changes in operating assets and liabilities:
Decrease in prepaid expenses and receivables
Decrease (increase) in inventory
Increase (decrease) in trade payables
Increase in other payables and deferred revenue
Net cash used in operating activities
CASH FLOWS - INVESTING ACTIVITIES:
Purchase of equipment
Sale of equipment
Investment in joint venture
Restricted deposit withdrawn (funded)
Installation of a production facility
Participation of Israeli Innovation Authority in production facility investment
Restricted deposit funded
Other
Net cash used in investing activities
CASH FLOWS - FINANCING ACTIVITIES:
Proceeds from issuance of shares and warrants, net
Proceeds from issuance of ordinary shares, preferred shares, warrants and prefunded warrants
Fund raising and issuance costs
Total proceeds from issuance of shares and warrants, net
Loan received from EIB
Repayment of bank loan
Grants recognized as liability for royalties
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR
CASH AND CASH EQUIVALENTS - END OF YEAR
Loss for the year
Depreciation (Note 8)
Amortization of right-of-use assets
Impairment loss of inventory
Impairment and closure net loss of Rotem 1 project
Royalty obligations initial recognition and adjustment
Provision
Share in loss of joint venture
Loss from write-down of production line
Fair value adjustment of share options’ liability
Other financial expenses
Share-based payment (Note 14C)
Net cash used in operating activities
Increase in trade and other receivables
Decrease (increase) in inventory
Increase in trade payables
Increase (decrease) in other payables and deferred revenue
Exercise of options, prefunded warrants and warrants
Net cash provided by financing activities

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED DEPOSITS
EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS AND RESTRICTED DEPOSITTS
CASH AND CASH EQUIVALENTS AND RESTRICTED DEPOSITS - BEGINNING OF YEAR
CASH AND CASH EQUIVALENTS AND RESTRICTED DEPOSITS - END OF YEAR
B. Supplemental information:
Investing and financing activities not involving cash flows
Recognition of operating lease liability and right-of-use asset
Borrowing costs capitalized
Reclassification of share options and warrants from liabilities to equity
Supplier’s credit for the acquisition of equipment
Conversion of unpaid salary to Ordinary Shares and warrants
Change in terms of warrants
Deemed Dividend For Down-round Adjustments
Reclassification of warrants from equity to liabilities
Cash paid during the year for -
Interest (net of amounts capitalized)
C. Reconciliation of cash and cash equivalents, and restricted DEPOSITS reported in the statement of financial position
Cash and cash equivalents
Restricted bank deposits

Comments